Miromatrix Announces Participation in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Miromatrix Medical Inc. (NASDAQ: MIRO) announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17, 2022, at 2:00 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Miromatrix Medical Inc. (NASDAQ: MIRO) announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17, 2022, at 2:00 PM ET. The company specializes in bioengineering fully transplantable organs, with a focus on addressing organ shortages through its proprietary perfusion technology platform. Miromatrix aims to help save lives by developing human livers and kidneys. Interested parties can listen to the live event by contacting their BTIG representative.
Positive
- Participation in a significant industry conference provides visibility and networking opportunities.
- Pioneering technology in bioengineering organs addresses critical organ shortages.
Negative
- None.
Details
News Market Reaction – MIRO
The recorded move for MIRO in the trading session of this news was +0.49%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EDEN PRAIRIE, Minn., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference.
Miromatrix Medical's management is scheduled to present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Thursday, February 17, 2022 at 2:00 PM ET.
BTIG hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, please contact your BTIG representative with interest.
About Miromatrix
Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com.
Investor Contact
Greg Chodaczek
347-620-7010
ir@miromatrix.com
Media Contact:
press@miromatrix.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.